Establishment and characterization of six human melanoma xenograft lines. 1990

E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
Institute for Cancer Research, Norwegian Radium Hospital, Montebello, Oslo.

Six new human melanoma xenograft lines differing considerably in biological properties were established in athymic nude mice and characterized with respect to growth in vivo. Mean volume-doubling time ranged from 1.8 to 17.7 days, mean necrotic fraction from 7 to 39%, and mean fraction of cells in S from 11 to 31% at a tumor volume of 500 mm3. DNA-index and median chromosome number were in the ranges 1.15-1.76 and 46-80, respectively. The lines were all highly malignant by histopathological criteria, but showed significant differences with respect to cell type, cellular pleomorphism, nuclear atypia, nucleolar prominence, and mitotic activity. Several biological characteristics of the donor patients' melanomas were retained in the xenograft lines. All lines showed a human karyotype and the histological appearance was very similar to that of the source tumor material. The distribution of cells in the cell cycle was comparable to that reported for melanomas in man. The six melanoma xenograft lines constitute a tumor panel that shows great promise for future studies of the biology and treatment sensitivity of malignant melanoma.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell

Related Publications

E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
July 1993, International journal of cancer,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
February 1992, Cancer research,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
March 1993, Gynecologic oncology,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
March 1991, Hiroshima journal of medical sciences,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
November 2004, The Journal of veterinary medical science,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
January 2024, Frontiers in veterinary science,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
June 2016, Endocrine pathology,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
June 1986, British journal of cancer,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
May 1991, Japanese journal of cancer research : Gann,
E K Rofstad, and A Wahl, and T Stokke, and J M Nesland
April 2012, Journal of neurosurgery,
Copied contents to your clipboard!